Effect of baseline cancer pain on the efficacy of immunotherapy in lung cancer patients

CONCLUSIONS: Baseline cancer pain is a negative prognostic factor for lung cancer patients receiving immunotherapy. Patients with baseline cancer pain may have a worse survival prognosis if they develop breakthrough pain.PMID:37691656 | PMC:PMC10482640 | DOI:10.21037/jtd-23-375

Source: Journal of Thoracic Disease - September 11, 2023 Category: Respiratory Medicine Authors: Huan Zhou Jingwen Wei Wei Sun Zhengbo Song Source Type: research